on New To The Street
Acurx Pharmaceuticals Expands Media Partnership with New to The Street
New to The Street has announced an expanded media partnership with Acurx Pharmaceuticals, Inc. The late-stage biopharmaceutical company focuses on developing a new class of antibiotics for complex bacterial infections. The agreement encompasses long-form televised interviews, national TV commercials, and participation in investor forums.
The partnership will leverage platforms such as Bloomberg Television, Fox Business, and New to The Street’s YouTube channel. Acurx will engage with accredited investors via AccreditedEvents.com, broadening its audience reach.
New to The Street's CEO, Vince Caruso, emphasized the partnership's role in strengthening Acurx’s visibility within the biotech investment community. Acurx's product pipeline, including its lead candidate ibezapolstat, aligns with this strategic media exposure.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all New To The Street news